Neurocrine Biosciences | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 20.1M 2M 2025-06
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
ALKERMES USD 99.21M 39.37M 2025-06
Alnylam Pharmaceuticals USD 102.39M 4.99M 2025-06
Amgen USD 18.03B 15.63B 2025-06
Biogen USD 408.4M 16.9M 2025-06
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Cytokinetics USD 68.54M 54.6M 2025-06
Dynavax Technologies USD 2.7M 1.63M 2025-06
Exelixis USD 25.82M 17.02M 2025-07
Gilead Sciences USD 582M 155M 2025-06
Halozyme Therapeutics USD 18.69M 1.38M 2025-06
Incyte USD 1.41B 1.21B 2025-06
Ionis Pharmaceuticals USD 22.8M 5.34M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Pfizer USD 5.17B 74M 2025-06
Prothena USD 7.77M 2.56M 2024-12
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Repligen USD 26.94M 5.2M 2025-03
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
Teva Pharmaceutical Industries USD 2.5B 208M 2025-06
Ultragenyx Pharmaceutical USD 34.24M 13.21M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06


Neurocrine Biosciences Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.